The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Mylan N.V. (NASDAQ: MYL) who purchased shares between February 16, 2016 and May 7, 2019. The action, which was filed in the United States District Court for the Western District of Pennsylvania, alleges that the Company violated federal securities laws.
1) the Food and Drug Administration’s investigation into the Company’s manufacturing plant in Morgantown, West Virginia was the result of whistleblower allegations, and not, as Mylan insinuated, the result of a “regular” inspection; and 2) defendants knew, or were reckless in not knowing that, as a result of Mylan’s continued efforts to remain uncooperative with the Food and Drug Administration, the Morgantown plant would continue to incur substantial setbacks.
Shareholders have until August 25, 2020 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
To learn more and keep informed, complete this form >